AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q3 2024 Earnings Conference Call November 8, 2024 8:00 AM ET
Company Participants
Allison Malkin – ICR
Dennis Dean – Interim Chief Executive Officer and Chief Financial Officer
Conference Call Participants
Joshua Raskin – Nephron Research LLC
Korinne Wolfmeyer – Piper Sandler
Operator
Greetings, and welcome to AirSculpt Technologies, Inc. Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host Ms. Allison Malkin from ICR. Thank you Ms. Malkin. You may begin.
Allison Malkin
Good morning, everyone, and thank you for joining us to discuss AirSculpt Technologies’ results for the third quarter of fiscal 2024. Joining me on the call today is Interim Chief Executive Officer and Chief Financial Officer, Dennis Dean.
Before we begin, I would like to remind you that this conference call may include forward-looking statements. These statements may include our future expectations regarding financial results and guidance, market opportunities and our growth. Risks and uncertainties that may impact these statements and could cause actual future results to differ materially from currently projected results are described in this morning’s press release and the reports we will file with the SEC. All of which can be found on our website at investors.airsculpt.com.
We undertake no obligation to revise or update any forward-looking statements or information, except as required by law. During our call today, we will also reference certain non-GAAP financial measures. We use non-GAAP measures in some of our financial discussions as we believe they more accurately represent the true operational performance and underlying results of our business. A reconciliation of these measures can be found in our earnings release as filed this morning and in our most recent 10-Q, which will also be available on our website. For today’s call, Dennis will begin with an overview of the quarter and share an update on our strategic initiatives, followed by a review of our financials and guidance. Following our prepared remarks, we will open the call to take the questions you have for us today.
With that, I’ll turn the call over to Dennis.
Dennis Dean
Good morning, everyone, and thank you for joining today’s call. Our third quarter results were in line with our expectations and included solid progress on our back-to-basics priorities. These priorities focus on three initiatives: improving the conversion of current and prior lead volumes into perform cases, ensuring our recent de novo center openings are successful and better in cost management. We believe this approach has us on the right track to improve performance as we navigate a continuing dynamic macro environment.